Clinical trial
Divalproex Sodium in the Treatment of PTSD (Post-Traumatic Stress Disorder)
NCT00108576 · VA Office of Research and Development, U.S. Fed · Completed
Key facts
| NCT number | NCT00108576 |
|---|---|
| Title | Divalproex Sodium in the Treatment of PTSD (Post-Traumatic Stress Disorder) |
| Official title | Divalproex Sodium in the Treatment of PTSD: A Placebo-Controlled Study |
| Lead sponsor | VA Office of Research and Development, U.S. Fed |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | PTSD |
| Intervention type | Drug, Other |
| Interventions | Divalproex, placebo |
| Enrollment | 101 |
| Start date | Oct 1, 2003 |
| Primary completion | Aug 1, 2005 |
| Completion | Sep 1, 2005 |
| First posted | Apr 18, 2005 |
| Last update posted | Oct 21, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: